Cargando…

Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial

PURPOSE: Tumor bleeding is a major complication in inoperable gastric cancer. The study aim was to investigate the effects of proton pump inhibitor (PPI) treatment for the prevention of gastric tumor bleeding. MATERIALS AND METHODS: This study was a prospective double-blind, randomized, placebo-cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Young-Il, Kim, Mi-Jung, Park, Sook Ryun, Kim, Hark Kyun, Cho, Soo-Jeong, Lee, Jong Yeul, Kim, Chan Gyoo, Kim, Gwang Ha, Park, Moo In, Nam, Byung-Ho, Park, Young Iee, Choi, Il Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Gastric Cancer Association 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489541/ https://www.ncbi.nlm.nih.gov/pubmed/28680717 http://dx.doi.org/10.5230/jgc.2017.17.e15

Ejemplares similares

Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial
por: Kim, Young-Il, et al.
Publicado: (2021)

Proton pump inhibitor-induced fundic gland polyposis
por: Park, Young Joo, et al.
Publicado: (2017)

A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines
por: Eom, Sang Soo, et al.
Publicado: (2022)

Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer
por: Yu, Jesang, et al.
Publicado: (2021)

Is the Reinitiation of Antiplatelet Agents Safe at 1 Week after Gastric Endoscopic Submucosal Dissection? Assessment of Bleeding Risk Using the Forrest Classification
por: Lee, Jong Yeul, et al.
Publicado: (2017)

A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine
por: Lee, Keun-Wook, et al.
Publicado: (2017)

Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy
por: Lee, Hyun-Jung, et al.
Publicado: (2021)

Proton Pump Inhibitor-Related Gastric Mucosal Changes
por: Kim, Gwang Ha
Publicado: (2021)

Preoperative Plasma Fibrinogen Level Is a Useful Predictor of Adjacent Organ Involvement in Patients with Advanced Gastric Cancer
por: Lee, Sang Eok, et al.
Publicado: (2012)

Survival Benefit of Perioperative Chemotherapy in Patients with Locally Advanced Gastric Cancer: a Propensity Score Matched Analysis
por: Eom, Bang Wool, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

A Proton Pump Inhibitor’s Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study
por: Jo, Yunju, et al.
Publicado: (2015)

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
por: Song, Myung Jin, et al.
Publicado: (2021)

Predictive Factors of Response to Proton Pump Inhibitors in Korean Patients With Gastroesophageal Reflux Disease
por: Kim, Sung Eun, et al.
Publicado: (2015)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
por: Kim, Young-Il, et al.
Publicado: (2013)

Effects of the Addition of Mosapride to Gastroesophageal Reflux Disease Patients on Proton Pump Inhibitor: A Prospective Randomized, Double-blind Study
por: Lim, Hyun Chul, et al.
Publicado: (2013)

A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients
por: Kim, Hark Kyun, et al.
Publicado: (2011)

Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
por: Jung, Da Hyun, et al.
Publicado: (2021)

Effectiveness of proton pump inhibitor in unexplained chronic cough
por: Park, Hye Jung, et al.
Publicado: (2017)

Associations Between Asthma Diagnosis/Asthma Exacerbation and Previous Proton-Pump Inhibitor use: A Nested Case-Control Study Using a National Health Screening Cohort
por: Choi, Hyo Geun, et al.
Publicado: (2022)

Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?
por: Jeon, Hye Kyung, et al.
Publicado: (2017)

Endoscopic Management of Tumor Bleeding from Inoperable Gastric Cancer
por: Kim, Young-Il, et al.
Publicado: (2015)

Failure of a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of H. pylori Eradication in H. pylori-Infected Patients with Functional Dyspepsia
por: Hong, Su Jin, et al.
Publicado: (2011)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Esophageal Involvement of Pemphigus Vulgaris Associated with Upper Gastrointestinal Bleeding
por: Chang, Sooyun, et al.
Publicado: (2014)

Safety Analysis of Panax Ginseng in Randomized Clinical Trials: A Systematic Review
por: Kim, Young-Sook, et al.
Publicado: (2015)

Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer
por: Kim, Young-Il, et al.
Publicado: (2016)

Effectiveness of a Novel Covered Stent without External Thread Fixation for Anastomotic Leakage after Total or Proximal Gastrectomy for Gastric Cancer
por: Kim, Young-Il, et al.
Publicado: (2021)

Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma
por: Jung, Da Hoon, et al.
Publicado: (2014)

Comparison of bleeding risks among non-vitamin K antagonist oral anticoagulants using the Korea adverse event reporting system database
por: Ko, Young-Jin, et al.
Publicado: (2019)

Clinical Outcomes of Endoscopic Hemostasis for Bleeding in Patients with Unresectable Advanced Gastric Cancer
por: Song, In Ji, et al.
Publicado: (2017)

Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) Study
por: Kim, Joon Sung, et al.
Publicado: (2018)

Discrepancy between Clinical and Final Pathological Evaluation Findings in Early Gastric Cancer Patients Treated with Endoscopic Submucosal Dissection
por: Kim, Young-Il, et al.
Publicado: (2016)

Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
por: Kim, Youlim, et al.
Publicado: (2019)

Effect of Evening Primrose Oil on Korean Patients With Mild Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Study
por: Chung, Bo Young, et al.
Publicado: (2018)

Efficacy and safety of herbal medicine (Dangguijagyag-san) for primary dysmenorrhea: study protocol for a randomized, double-blind, placebo-controlled, parallel-group, multi-center trial
por: Woo, Hye Lin, et al.
Publicado: (2020)

Efficacy of endoscopic management for anastomotic leakage after gastrectomy in patients with gastric cancer
por: Kim, Young-Il, et al.
Publicado: (2021)

FAM167A is a key molecule to induce BCR-ABL-independent TKI resistance in CML via noncanonical NF-κB signaling activation
por: Yang, Taewoo, et al.
Publicado: (2022)

Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis
por: Lee, Chang Min, et al.
Publicado: (2016)

Impact of proton pump inhibitors on the risk of small bowel or colorectal bleeding: A systematic review and meta‐analysis
por: Jung, Yoon Suk, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pj76nd06c2hfjmn6dspmra0itm